Valuation: Sysmex Corporation

Market Cap 1,187B 7.51B 6.69B 6.19B 5.6B 10.56B 708B 10.68B 74.25B 29.14B 372B 28.16B 27.57B P/E 2027 *
29.6x
P/E 2028 * 24.1x
Enterprise Value 1,208B 7.64B 6.81B 6.3B 5.7B 10.75B 721B 10.87B 75.58B 29.65B 379B 28.66B 28.06B EV / Sales 2027 *
2.2x
EV / Sales 2028 * 2.09x
Free-Float
71.34%
Yield 2027 *
2.06%
Yield 2028 * 2.14%
1 day+4.82%
1 week+7.46%
Current month+6.17%
1 month+4.56%
3 months+26.17%
6 months+40.96%
Current year+27.08%
1 week 11.35
Extreme 11.35
12.4
1 month 11.15
Extreme 11.15
12.4
Current year 8.01
Extreme 8.01
12.9
1 year 8.01
Extreme 8.01
12.9
3 years 8.01
Extreme 8.01
22
5 years 8.01
Extreme 8.01
46.27
10 years 8.01
Extreme 8.01
46.27
Manager TitleAgeSince
Chief Executive Officer 77 31/03/2018
Director of Finance/CFO 56 -
President 65 31/03/2026
Director TitleAgeSince
Chairman 77 31/03/2013
Director/Board Member 65 31/05/2019
Director/Board Member 71 31/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
+4.82%+7.46% - - 7.51B
+0.80%-2.39%-21.19%+3.85% 174B
+0.87%+5.67%-21.63%+12.01% 114B
+0.68%-1.27%-2.92%+27.96% 114B
+0.86%+17.79%-43.75%+5.83% 89.64B
+0.10%+1.27%+3.53%+80.36% 64.96B
-0.47%+5.71%+14.57%+81.93% 56.09B
+1.01%+2.89%+2.81%-24.86% 52.94B
+0.99%+4.63%-13.13%+29.62% 43.6B
+1.00%+1.56%-8.11%-13.66% 32.77B
Average +1.09%+4.44%-9.98%+22.56% 82.44B
Weighted average by Cap. +0.79%+3.58%-13.55%+20.34%

Financials

2027 *2028 *
Net sales 549B 3.47B 3.09B 2.86B 2.59B 4.88B 328B 4.94B 34.33B 13.47B 172B 13.02B 12.75B 577B 3.65B 3.26B 3.01B 2.73B 5.14B 345B 5.2B 36.14B 14.18B 181B 13.71B 13.42B
Net income 40.33B 255M 227M 211M 191M 359M 24.08B 363M 2.52B 990M 12.66B 957M 937M 49.41B 313M 279M 258M 233M 440M 29.5B 445M 3.09B 1.21B 15.51B 1.17B 1.15B
Net Debt 21.13B 134M 119M 110M 99.81M 188M 12.62B 190M 1.32B 519M 6.63B 502M 491M 20.46B 129M 115M 107M 96.62M 182M 12.21B 184M 1.28B 502M 6.42B 485M 475M
Projected Income Statement - Annual - Sysmex Corporation
Logo Sysmex Corporation
SYSMEX CORPORATION is a Japan-based company engaged in the development, manufacture, sale, servicing and import/export of clinical testing instruments and reagents for the medical field. It proposes solutions to address the diverse challenges faced by medical institutions by integrating a wide range of products and services, including software, maintenance for clinical testing equipment, and academic support. It operates business through four segments centered on regional controlling entity, including Headquarters, Americas, Europe, Middle East and Africa (EMEA), China and Asia-Pacific (AP). Headquarters segment operates with the Company itself acting as the controlling entity, responsible for product development, manufacture and others, consolidated subsidiaries within this segment handle the development and manufacturing of certain products, as well as domestic and overseas sales. Americas, Europe, EMEA, China and AP segments operate business in their respective regions.
Employees
10,861
Date Price Change Volume
21/10/26 US$12.39 +4.82% 21,632
20/10/26 US$11.82 +2.80% 1,192,007
19/10/26 US$11.50 -1.47% 960,766
16/10/26 US$11.67 +0.60% 1,500,117
15/10/26 US$11.60 +0.61% 589,772
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Sysmex Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,960.50JPY
Average target price
2,139.29JPY
Spread / Average Target
+9.12%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sysmex Corporation